Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
reverse merger
Biotech
Bolt strikes Prana reverse merger alongside $120M financing
A syndicate of investors is backing Bolt with $120 million upfront and a potential $60 million more through warrants.
Marissa Russo
Oct 23, 2026 9:00am
Reverse mergers rebound to highest level since 2021: report
Oct 21, 2026 3:12am
Paragon Labs imports Apogee leadership after AbbVie buyout
Oct 13, 2026 8:44am
After failed acquisition, Lisata finds lifeline in Marea merger
Sep 17, 2026 10:00am
Atopic dermatitis biotech heads to Nasdaq via reverse merger
Sep 17, 2026 7:40am
Werewolf transforms into Ambros via reverse merger
Aug 21, 2026 9:50am